JULIANA ROSSI: Open Payments
NPI 1851532493 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 17 payments from 4 companies in 2025. Trend: 2023 $396 · 2024 $324 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $153 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $18 |
Products named: INGREZZA, Ozempic, Wegovy, Rybelsus, MOUNJARO, HETLIOZ, FANAPT.
Industry payments across DE — which companies pay providers there.
